Current filters:


Popular Filters

6801 to 6825 of 6997 results

AstraZeneca in patent settlement deal with Handa over Seroquel XR


Anglo-Swedish drug major AstraZeneca (LSE: AN) yesterday revealed that it has entered into a settlement…

AstraZenecaGenericsHanda PharmaceuticalsNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XR

Lundbeck partners with Proximagen, buying around a 9%equity stake in the firm


Danish central nervous system specialist Lundbeck (LUND: DC) and the UK’s Proximagen Group (AIM:…

LundbeckMergers & AcquisitionsNeurologicalPharmaceuticalProximagenResearch

Pfizer partners with USA’s NABP to warn about counterfeit Rx drugs


Global drugs behemoth Pfizer (NYSE: PFE) and the USA’s National Association of Boards of Pharmacy…

Markets & MarketingNorth AmericaPfizerPharmaceutical

Astellas drops development of blood thinner darexaban


Japanese drug major Astellas Pharma (TYO: 4503) says it has decided to discontinue the global development…

Astellas PharmaCardio-vasculardarexabanPharmaceuticalRegulationResearch

Takeda and Pronova file for triglyceride lowererTAK-085 approval in Japan


Norway-based lipid therapies specialist Pronova BioPharma says that its partner, Takeda Pharmaceutical…

Asia-PacificCardio-vascularPharmaceuticalRegulationTakeda Pharmaceuticals

Novel disease-modifying therapies will drive MS market to $11.5 billion in 2015


The launch of several premium-priced novel disease-modifying therapies, including four oral agents, will…

BiotechnologyGlobalMarkets & MarketingNeurologicalPharmaceutical

Cost benefit analysis of cervical cancer vaccines sees Gardasil beat Cervarix


An analysis of cervical-cancer vaccine has shown that Merck & Co’s (NYSE: MRK) Gardasil (human papillomavirus…

CervarixEuropeGardasilGlaxoSmithKlineMerck & CoPharmaceuticalPricingVaccines

Onyx Pharma files NDA for multiple myeloma drug carfilzomib


California, USA-based Onyx Pharmaceuticals (Nasdaq: ONXX) says it has completed the New Drug Application…

carfilzomibNorth AmericaOncologyOnyx PharmaceuticalsPharmaceuticalRegulation

GAVI Alliance delivers on its promise to tackle diarrhea and pneumonia


The GAVI Alliance announced this week that it will provide funding for 16 more developing countries to…


Executive appointments at Merck & Co, Actelion and Jazz Pharma


US drug giant Merck & Co (NYSE: MRK) has appointed Cuong Viet Do as chief strategy officer, effective…

ActelionBiotechnologyJazz PharmaceuticalsManagementMerck & CoPharmaceutical

Canada’s national health spending crunch the result of public insurance programs, not drug costs


Claims that prescription drug costs are at the root of Canada’s health spending crisis are unfounded…

HealthcareNorth AmericaPharmaceuticalPricing

MVA-B Spanish HIV vaccine shows 90% immune response in humans


Phase I clinical trials developed by Spanish Superior Scientific Research Council (CSIC) together with…


Off-label use of antipsychotics for some conditions not supported by evidence, says US govt agency


There is little evidence to support the use of atypical antipsychotic drugs for some treatments other…

NeurologicalNorth AmericaPharmaceuticalRegulation

Psoriasis drug market set to see strong growth until 2018, reaching a value of $6.7 million


The psoriasis therapeutics market is forecast to show high growth until 2018 and market research firm…

DermatologicalsGlobalImmunologicalsMarkets & MarketingPharmaceutical

GPhA joins in US drug shortages challenge, urging “unprecedented multi-stakeholder collaboration”


With shortages of prescription drugs continuing in the USA, the country’s Generic Pharmaceutical…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalRegulation

Novo Nordisk files for EU approval of ultra-long-acting insulins Degludec and DegludecPlus


Danish insulin giant Novo Nordisk NVO: N) has made the first regulatory approval submissions, to the…

DegludecDiabetesEuropeNovo NordiskPharmaceuticalRegulation

Lilly’s Alimta shows benefit in hard-to-treat lung cancer patients


US drug major Eli Lilly (NYSE: LLY) says that a new subgroup analysis of data from the pivotal Phase…

AlimtaEli LillyOncologyPharmaceuticalResearch

Ipsen enters deal with Photocure to commercialize Hexvix


French drugmaker Ipsen (Euronext: IPN) has entered into a partnership with Norway-based Photocure (OSE:…


Mesoblast and Lonza establish strategic global manufacturing alliance for stem cell products


Australian regenerative medicine company Mesoblast (ASX: MSB) and Switzerland-based Lonza Group (SWS:…


US FDA communicates concern about drospirenone-containing birth control pills


The US Food and Drug Administration (FDA) is informing the public that it has not yet reached a conclusion,…

BayerDrospirenone and Ethinyl EstradiolNorth AmericaPharmaceuticalRegulationReproductiveYasminYaz

6801 to 6825 of 6997 results

Company Spotlight



Back to top